Business Standard

Drug shortages in US market, compliance gains positive for pharma exporters

Shortage of drugs in the US market is at five-year highs

drugs
Premium

The coronavirus (Covid-19) outbreak is expected to help Indian companies gain market share. Photo: Shutterstock

Ram Prasad Sahu
Concerns over price erosion in the US market, which has impacted the revenue growth of Indian pharma majors over the last four years, could be reversing. The drug shortages in the US market have increased by 37 per cent since December 2017. Kunal Randeria of Antique Stock Broking says drug shortages are at five-year highs and there is a direct correlation between drug shortage and prices. This is evident as price erosion peaked in 2017 when shortages were at their lowest levels.

Manufacturing and quality issues remain the single biggest reason for drug shortages, according to the US Federal Drug

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Apr 23 2020 | 6:30 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com